Skip to content
MedsAcross

Fixed-dose combination

Sodium nitrite and Sodium thiosulfate

Also known as sodium nitrite, sodium thiosulfate
Available on requestOrphan
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Sodium nitrite and Sodium thiosulfate is a fixed-dose combination medicine indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. It is available as kits. MedsAcross supplies Sodium nitrite and Sodium thiosulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
14 January 2011
EU status
Not recorded
Orphan designation
Yes
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Dosage forms
Kit
Fixed-dose combination of
Sodium nitrite, Sodium thiosulfate

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

NITHIODOTE is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. When the diagnosis of cyanide poisoning is uncertain, carefully weigh the potentially life-threatening risks associated with NITHIODOTE against the potential benefits, especially if the patient is not in extremis. NITHIODOTE, an antidote, is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. Use with caution if the diagnosis of cyanide poisoning is uncertain.

Source: US FDA prescribing information

How it works

Cyanide is an extremely toxic poison. In the absence of rapid and adequate treatment, exposure to a high dose of cyanide can result in death within minutes due to the inhibition of cytochrome oxidase resulting in arrest of cellular respiration. Specifically, cyanide binds rapidly with cytochrome a3, a component of the cytochrome c oxidase complex in mitochondria. Inhibition of cytochrome a3 prevents the cell from using oxygen and forces anaerobic metabolism, resulting in lactate production, cellular hypoxia and metabolic acidosis. In massive acute cyanide poisoning, the mechanism of toxicity may involve other enzyme systems as well. Signs and symptoms of acute systemic cyanide poisoning may develop rapidly within minutes, depending on the route and extent of cyanide exposure.

Source: US FDA prescribing information

Dosing overview

If clinical suspicion of cyanide poisoning is high, administer NITHIODOTE without delay and in conjunction with appropriate airway, ventilatory, and circulatory support. The expert advice of a regional poison control center may be obtained by calling 1-800-222-1222. Dosing: Age Intravenous Dose of Sodium Nitrite and Sodium Thiosulfate Adults 1) Sodium Nitrite -10 mL of sodium nitrite at the rate of 2.5 to 5 mL/minute 2) Sodium Thiosulfate - 50 mL of sodium thiosulfate immediately following administration of sodium nitrite. Children 1) Sodium Nitrite - 0.2 mL/kg (6 mg/kg or 6-8 mL/m 2 BSA) of sodium nitrite at the rate of 2.5 to 5 mL/minute not to exceed 10 mL 2) Sodium Thiosulfate - 1 mL/kg of body weight (250 mg/kg or approximately 30-40 mL/m 2 of BSA) not to exceed 50 mL total dose immediately following administration of sodium nitrite.

Source: US FDA prescribing information

Warnings and precautions

Boxed warning (life threatening hypotension and methemoglobin formation): Sodium nitrite can cause serious adverse reactions and death in humans, even at doses less than twice the recommended therapeutic dose. Sodium nitrite causes hypotension and methemoglobin formation, which diminishes oxygen carrying capacity. Hypotension and methemoglobin formation can occur concurrently or separately. Methemoglobinemia: Sodium nitrite reacts with hemoglobin to form methemoglobin and should be used with caution in patients known to have anemia. Monitor oxyhemoglobin and methemoglobin levels by pulse co-oximetry or other measurements. Optimally, the sodium nitrite dose should be reduced in proportion to the oxygen carrying capacity. Smoke inhalation: Carbon monoxide contained in smoke can result in the formation of carboxyhemoglobin that can reduce the oxygen carrying capacity of the blood.

Source: US FDA prescribing information

Side effects

There have been no controlled clinical trials conducted to systematically assess the adverse events profile of sodium nitrite or sodium thiosulfate. The medical literature has reported the following adverse events in association with sodium nitrite or sodium thiosulfate administration. These adverse events were not reported in the context of controlled trials or with consistent monitoring and reporting methodologies for adverse events. Therefore, frequency of occurrence of these adverse events cannot be assessed. Most common adverse reactions are: Sodium nitrite: syncope, hypotension, tachycardia, palpitations, dysrhythmia, methemoglobinemia, headache, dizziness, blurred vision, seizures, confusion, coma. Sodium thiosulfate: hypotension, headache, disorientation.

Source: US FDA prescribing information

Storage

Store at controlled room temperature between 20°C and 25°C (68°F - 77°F), excursions permitted to 15-30°C (59 to 86°F). Do not freeze. Protect from direct light.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Sodium nitrite and Sodium thiosulfate, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Nithiodote kitSodium nitrite and Sodium thiosulfateHope PharmaceuticalsUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 14 January 2011Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Sodium nitrite and Sodium thiosulfate available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Sodium nitrite and Sodium thiosulfate and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Sodium nitrite and Sodium thiosulfate have?

The catalogue lists 1 brand names for Sodium nitrite and Sodium thiosulfate, including Nithiodote.

Is Sodium nitrite and Sodium thiosulfate approved by the US FDA?

Yes. The US FDA first approved Sodium nitrite and Sodium thiosulfate on 14 January 2011, according to Drugs@FDA.

Does Sodium nitrite and Sodium thiosulfate need cold chain shipping?

No listed presentation of Sodium nitrite and Sodium thiosulfate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. NITHIODOTE prescribing information (Hope Pharmaceuticals). U.S. National Library of Medicine, DailyMed. Retrieved 6 October 2025

Request Sodium nitrite and Sodium thiosulfate for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.